SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001088875-19-000014
Filing Date
2019-01-15
Accepted
2019-01-15 07:21:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 RubiusTherapeutics12312018.txt SC 13G 9684
  Complete submission text file 0001088875-19-000014.txt   11166
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G

Mailing Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Subject) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90775 | Film No.: 19526196
SIC: 2836 Biological Products, (No Diagnostic Substances)